‘Access’ Trumps Safety in New Abortion Shield Laws

Allowing abortion pill prescriptions to be shipped without a patient’s name will contribute to safety risks.

Share this story

A staff member at Alamo Women’s Clinic prepares Mifepristone, the first pill in a medical abortion, for a patient in Carbondale, Ill., April 9, 2024.

Evelyn Hockstein/Reuters

The Clinton-era slogan for the pro-abortion movement was that the practice should be “safe, legal, and rare.” But nowadays, abortion advocates don’t want it to be rare, and they aren’t exactly married to safety. To circumvent pro-life states’ laws, abortion advocates are cutting corners, with women’s health sacrificed at the altar of access. Their latest effort: allowing mifepristone, the abortion pill, to be shipped without a patient’s name on the prescription.

The New York Times has reported on a wave of new abortion “shield laws” coming to blue states, dubbing New York’s version “Shield Law 2.0.” Beyond the 1.0 versions, which prohibited state law enforcement and judicial systems from cooperating with pro-life states enforcing laws against abortion, the new wave of shield laws is focused on insulating doctors and others involved in abortion from scrutiny and identification for interstate mifepristone shipments.

JG

About the Author

John Gerardi

John Gerardi is the executive director of Right to Life of Central California in Fresno. A lawyer and the founding CEO and current development director of the Obria Medical Clinics of Central California, he hosts the radio shows and podcasts The John Gerardi Show and Right to Life Radio.

Comments

Advertisement

Advertisement